Recap: Oncternal Therapeutics Q2 Earnings

Oncternal Therapeutics ONCT reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Oncternal Therapeutics reported in-line EPS of $-0.23 versus an estimate of $-0.23.

Revenue was down $692 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 7.27% drop in the share price the next day.

To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.